HealthCare Global Enterprises Ltd. Extends Timeline for Vizag Hospital Acquisition
Bangalore, India – March 29, 2026 – HealthCare Global Enterprises Ltd. (HCG) announced an extension to the timeline for the acquisition of shares in Vizag Hospital and Cancer Research Centre Private Limited (Vizag Hospital). The announcement, made today, details a second amendment to both the Share Purchase Agreement (SPA) and the Shareholders Agreement (SHA) initially established in June 2024.The SPA outlines a plan for HCG to acquire an additional 34% of Vizag Hospital's equity share capital. Originally scheduled within 18 months of the first closing date of October 2, 2024, the completion date has been extended by three weeks. This adjustment necessitates the acquisition of the additional 34% stake prior to the revised timeline.
According to the terms of the SPA and SHA, no other material changes were made beyond the adjustments needed to reflect the revised timelines. The original agreements, amended previously on October 1, 2024, were first disclosed on June 28, 2024.
HCG’s stock trades on the National Stock Exchange (NSE) under the symbol HCG and on the Bombay Stock Exchange (BSE) under the symbol 539787.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.